The study covers a detailed analysis segmented by key business segments i.e. by type (Oil, Perfume, Capsules, Bath Soak, Sunscreen and Others) , by application (Supermarkets/Hypermarkets, Convenience Stores, Independent Retailers, Online Sales and Others) and major geographies. Research Analyst at AMA predicts that North America Vendors will contribute to the maximum growth of Global Cannabidiol Products (CBD Products) market throughout the predicted period.
What is Cannabidiol Products (CBD Products)?
Cannabis, also referred to as marijuana, is a psychoactive substance derived from the Cannabis plant that is commonly used for medicinal or recreational purposes. The legalization of cannabis and cannabis derivatives such as cannabidiol (CBD). People can now use cannabis in a healthy manner while still benefiting from its medicinal properties, because of its legalization. As a result, many countries across the world are increasingly legalizing the use of cannabis. Because of its lack of psychoactive effects, cannabidiol is most commonly used for medicinal purposes. Cannabidiol oil is used in a variety of medical applications, including anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation relief.
The competition is expected to become even more intense in the years to come due to entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the markets competitive landscape and offers information on the products offered by various leading companies. Additionally, this Cannabidiol Products (CBD Products) market analysis report suggests strategies Vendors can follow and recommends key areas they should focus on, in order to take maximum benefits of growth opportunities.
The report offers several leading Vendors, including:
- Canopy Growth Corporation (Canada)
- Aurora Cannabis Inc. (Canada)
- MedMen (United States)
- Terra Tech Corp. (United States)
- Aphria Inc. (Canada)
- VIVO Cannabis Inc. (Canada)
- The Cronos Group (Canada)
- Medical Marijuana Inc. (United States)
- The Body Shop (United Kingdom)
- Cronos Group (Canada)
FDA recognizes the potential opportunities that cannabis or cannabis-derived compounds may offer and acknowledges the significant interest in these possibilities. However, FDA is aware that some companies are marketing products containing cannabis and cannabis-derived compounds in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act) and that may put the health and safety of consumers at risk.
Various Multinational Companies Investing in Cannabis Products
- High probabilities of product contamination
- Cannabis is still banned in Several Countries
Increase in R&D and Technological Innovation
Key highlights of the Global Cannabidiol Products (CBD Products) market Study:
CAGR of the market during the forecast period 2020-2026
Detailed information on factors that will accelerate the growth of the Cannabidiol Products (CBD Products) market for the next five years.
Forecast of the Global Cannabidiol Products (CBD Products) market size and its contribution to the parent market by type, application and by country.
Insights on upcoming trends and changes in consumer behaviour
Uncovering markets competitive landscape and in-depth information on various Vendors
Comprehensive information about factors that will challenge the growth of Cannabidiol Products (CBD Products) Vendors
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cannabidiol Products (CBD Products) market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cannabidiol Products (CBD Products) market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes Manufacturers of CBD Products, Suppliers of CBD Products, Wholesalers, Distributors and Retailers of CBD Products, CBD Manufacturers, Regulatory Bodies and Others.
This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.